We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
-$123M
Cap. Flow
-$215M
Cap. Flow %
-7.9%
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Healthcare 12.35%
3 Industrials 12.24%
4 Technology 10.34%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CS
2076
DELISTED
Credit Suisse Group
CS
-55,849
Closed -$219K
PGRWU
2077
DELISTED
Progress Acquisition Corp. Units
PGRWU
-14,180
Closed -$142K
EVOJU
2078
DELISTED
Evo Acquisition Corp. Unit
EVOJU
-13,216
Closed -$130K
BBBY
2079
DELISTED
Bed Bath & Beyond Inc
BBBY
-265,889
Closed -$1.62M
OSH
2080
DELISTED
Oak Street Health, Inc.
OSH
-30,970
Closed -$759K
CDAK
2081
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-38,019
Closed -$30K
LYLT
2082
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-50,930
Closed -$62K
AGGRU
2083
DELISTED
Agile Growth Corp Units
AGGRU
-10,900
Closed -$108K
FSTX
2084
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-148,354
Closed -$760K
FTEV
2085
DELISTED
FinTech Evolution Acquisition Group
FTEV
-22,229
Closed -$221K
ALBO
2086
DELISTED
Albireo Pharma Inc
ALBO
-19,943
Closed -$386K
IBER.U
2087
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
-13,850
Closed -$137K
ANAC.U
2088
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
-10,600
Closed -$105K
NVSAW
2089
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
-11,400
Closed -$1K
ATNX
2090
DELISTED
Athenex, Inc. Common Stock
ATNX
-8,029
Closed -$43K
GSQD.U
2091
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
-20,200
Closed -$201K
PRBM
2092
DELISTED
Parabellum Acquisition Corp.
PRBM
-20,100
Closed -$199K
PACX
2093
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
-30,241
Closed -$301K
OYST
2094
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-14,172
Closed -$80K
GLBLU
2095
DELISTED
Cartesian Growth Corporation Unit
GLBLU
-19,114
Closed -$191K
DS
2096
DELISTED
Drive Shack Inc.
DS
-189,027
Closed -$117K
ASAX
2097
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
-65,752
Closed -$647K
GIIX
2098
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
-35,000
Closed -$345K
MDH.U
2099
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
-16,700
Closed -$164K
MDH
2100
DELISTED
MDH Acquisition Corp.
MDH
-12,800
Closed -$126K

Similar funds

Ergoteles's Q4 2022 Portfolio in Review

As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.

  • Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
  • Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
  • Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
  • Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
  • Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
  • Ergoteles opened 704 new positions and closed 800 in Q4 2022.
  • Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.